13 assets in Mental Disorder

Therapeutic assets addressing Mental Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Gardasil 9 Vaccine Mental Disorder	Eunice Dube	P4	BB (65)
Hepatitis B Virus Vaccine Mental Disorder	Eunice Dube	P4	BB (65)
Dexasone Mental Disorder	Peking University Third Hospital	P3	B (60)
Donanemab Mental Disorder	Eli Lilly and Company	P3	B (60)
(2R,6R)-HYDROXYNORKETAMINE Mental Disorder	National Institute of Mental Health (NIMH)	P2	CCC (52)
ly03010 Mental Disorder	Luye Pharma Group Ltd.	P1	CCC (50)
Pegipanermin Mental Disorder	Inmune Bio, Inc.	P2	CCC (48)
Propofol Mental Disorder	Nyree Penn	P1	CC (43)
Teonanacatl Mental Disorder	University of Nebraska	P1	CC (43)
Levonorgestrel Mental Disorder	Rigshospitalet, Denmark	N/A	D (30)